Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) shot up 4.3% during mid-day trading on Monday . The company traded as high as $15.37 and last traded at $15.24. 2,673,140 shares were traded during trading, a decline of 41% from the average session volume of 4,517,835 shares. The stock had previously closed at $14.61.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group assumed coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, Oscar Health has a consensus rating of "Hold" and an average target price of $21.56.
Read Our Latest Stock Report on OSCR
Oscar Health Price Performance
The stock has a market capitalization of $4.01 billion, a price-to-earnings ratio of -799.25 and a beta of 1.75. The stock has a 50 day moving average price of $15.12 and a 200-day moving average price of $16.52. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.
Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Institutional Trading of Oscar Health
Several large investors have recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC boosted its position in shares of Oscar Health by 7.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock valued at $255,000 after acquiring an additional 844 shares during the last quarter. Summit Investment Advisors Inc. raised its stake in Oscar Health by 5.8% during the fourth quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock worth $280,000 after purchasing an additional 1,141 shares during the period. KBC Group NV boosted its holdings in Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock valued at $97,000 after purchasing an additional 1,328 shares during the last quarter. Arizona State Retirement System grew its stake in shares of Oscar Health by 3.1% in the 4th quarter. Arizona State Retirement System now owns 47,918 shares of the company's stock valued at $644,000 after buying an additional 1,454 shares during the period. Finally, Xponance Inc. grew its stake in shares of Oscar Health by 12.9% in the 4th quarter. Xponance Inc. now owns 14,394 shares of the company's stock valued at $193,000 after buying an additional 1,649 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Recommended Stories
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.